Ticker Details
Castle Biosciences, Inc.
IPO Date:	July 22, 2019
Sector:	Healthcare
Market Cap:	$752.49M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.02 | 3.13%
Avg Daily Range (30 D):	$0.52 | 2.29%
Avg Daily Range (90 D):	$0.55 | 2.44%

Institutional Daily Volume
Avg Daily Volume:	.26M
Avg Daily Volume (30 D):	.22M
Avg Daily Volume (90 D):	.26M

Trade Size
Avg Trade Size (Sh.):	55
Avg Trade Size (Sh.) (30 D):	43
Avg Trade Size (Sh.) (90 D):	44

Institutional Trades
Total Institutional Trades:	1,575
Avg Institutional Trade:	$1.35M
Avg Institutional Trade (30 D):	$1.58M
Avg Institutional Trade (90 D):	$1.46M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.47M
Avg Closing Trade (30 D):	$1.91M
Avg Closing Trade (90 D):	$1.62M
Avg Closing Volume:	49.32K

News

May 14, 2026 @ 10:22 AM Winner of My Stock-Picking Derby Sold Her Top Pick... Source: John Dorfman

Mar 9, 2026 @ 11:00 AM DecisionDx®-Melanoma’s i31-SLNB: Report ... Source: Castle Biosciences, Inc.

Feb 19, 2026 @ 10:46 PM Prospective Validation Study in JAAD Demonstrates ... Source: Castle Biosciences, Inc.

Dec 12, 2025 @ 12:00 PM Systematic Review and Meta-Analysis Confirms Tissu... Source: Caitlin C. Houghton, M.D.

Nov 17, 2025 @ 12:00 PM Castle Biosciences Earns a Houston Chronicle Top W... Source: Derek Maetzold

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.42	$-.49	$-.07
Diluted EPS	$-.43	$-.49	$-.07
Revenue	$339.92M	$83.68M	$87.01M
Gross Profit	$264.74M	$63.15M	$68.7M
Net Income / Loss	$-12.83M	$-14.52M	$-2.33M
Operating Income / Loss	$-33.29M	$-18.41M	$-3.83M
Cost of Revenue	$75.18M	$20.53M	$18.32M
Net Cash Flow	$-25.93M	$-52.97M	$31.17M
PE Ratio